Lenvakast 4mg Lenvatinib Capsules
Lenvakast 4mg contains Lenvatinib, a multikinase inhibitor used to treat thyroid cancer, kidney cancer, and certain liver cancers. It works by blocking multiple enzymes involved in tumour growth and angiogenesis (formation of new blood vessels), effectively starving the tumour of nutrients and slowing its growth. Lenvakast is taken orally once a day, usually in combination with other cancer treatments depending on the diagnosis. It has shown positive results in extending survival and delaying cancer progression. Side effects may include fatigue, diarrhea, high blood pressure, weight loss, and decreased appetite. Lenvatinib therapy requires close monitoring, particularly for blood pressure and liver function. Patients are advised to stay well-hydrated and report any unusual symptoms to their doctor. Lenvakast 4mg is a potent, targeted cancer therapy that offers new hope for patients with difficult-to-treat cancers, especially those who have not responded to traditional treatments.
Uses:
- Lenvakast 4mg is mostly used in the treatment of thyroid cancer, kidney cancer (renal cell carcinoma), and liver cancer (hepatocellular carcinoma).
Side Effects:
- Some common side effects of this medicine are fatigue, joint pain, muscle pain, nausea, drop in blood pressure, fatigue, diarrhea, and vomiting. If you have any serious problem, consult a doctor immediately.
How to Use:
- Lenvakast should be taken once daily, with or without food, always at the same time. The capsule should be swallowed with water, do not chew or break.
How It Works:
- Lenvatinib, which is the main ingredient of this medicine, stops the growth of cancer cells and prevents the formation of blood vessels (angiogenesis) necessary for them. This causes the tumour to slowly shrink.
What If You Forget to Take It:
- If you forget to take Lenvakast, take it as soon as you remember, but if less than 12 hours are left for the next dose, skip the missed dose. Do not take a double dose at all.
